Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Yeast Surface-Displayed H5N1 Avian Influenza Vaccines.

Lei H, Jin S, Karlsson E, Schultz-Cherry S, Ye K.

J Immunol Res. 2016;2016:4131324. doi: 10.1155/2016/4131324. Epub 2016 Dec 19.

2.

Universal and reusable virus deactivation system for respiratory protection.

Quan FS, Rubino I, Lee SH, Koch B, Choi HJ.

Sci Rep. 2017 Jan 4;7:39956. doi: 10.1038/srep39956.

3.
4.

Evaluation of protective efficacy induced by virus-like particles containing a Trichinella spiralis excretory-secretory (ES) protein in mice.

Lee SH, Kim SS, Lee DH, Kim AR, Quan FS.

Parasit Vectors. 2016 Jul 4;9(1):384. doi: 10.1186/s13071-016-1662-7.

5.

CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.

Lee YT, Ko EJ, Lee Y, Lee YN, Bian Z, Liu Y, Kang SM.

J Virol. 2016 Jul 11;90(15):6746-58. doi: 10.1128/JVI.00605-16. Print 2016 Aug 1.

6.

Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.

Ji X, Ren Z, Xu N, Meng L, Yu Z, Feng N, Sang X, Li S, Li Y, Wang T, Zhao Y, Wang H, Zheng X, Jin H, Li N, Yang S, Cao J, Liu W, Gao Y, Xia X.

Viruses. 2016 Apr 21;8(4):115. doi: 10.3390/v8040115.

7.

Progress in developing virus-like particle influenza vaccines.

Quan FS, Lee YT, Kim KH, Kim MC, Kang SM.

Expert Rev Vaccines. 2016 Oct;15(10):1281-93. doi: 10.1080/14760584.2016.1175942. Epub 2016 May 5. Review.

PMID:
27058302
8.

A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.

Lee YN, Lee YT, Kim MC, Gewirtz AT, Kang SM.

J Immunol. 2016 Mar 15;196(6):2637-45. doi: 10.4049/jimmunol.1501637. Epub 2016 Feb 10.

9.

Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells.

Kim KH, Lee YT, Hwang HS, Kwon YM, Jung YJ, Lee Y, Lee JS, Lee YN, Park S, Kang SM.

PLoS One. 2015 Oct 15;10(10):e0139916. doi: 10.1371/journal.pone.0139916. eCollection 2015.

10.

Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.

Lee YN, Kim MC, Lee YT, Hwang HS, Lee J, Kim C, Kang SM.

PLoS One. 2015 Sep 14;10(9):e0137822. doi: 10.1371/journal.pone.0137822. eCollection 2015.

11.

Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.

Lee YN, Kim MC, Lee YT, Kim YJ, Lee J, Kim C, Ha SH, Kang SM.

Antiviral Res. 2015 Oct;122:82-90. doi: 10.1016/j.antiviral.2015.08.001. Epub 2015 Aug 4.

12.

Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.

Kim MC, Lee JW, Choi HJ, Lee YN, Hwang HS, Lee J, Kim C, Lee JS, Montemagno C, Prausnitz MR, Kang SM.

J Control Release. 2015 Jul 28;210:208-16. doi: 10.1016/j.jconrel.2015.05.278. Epub 2015 May 21.

13.

Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses.

Patel JM, Kim MC, Vartabedian VF, Lee YN, He S, Song JM, Choi HJ, Yamanaka S, Amaram N, Lukacher A, Montemagno CD, Compans RW, Kang SM, Selvaraj P.

Nanomedicine. 2015 Jul;11(5):1097-107. doi: 10.1016/j.nano.2015.02.008. Epub 2015 Mar 6.

14.

Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.

Patel JM, Vartabedian VF, Kim MC, He S, Kang SM, Selvaraj P.

Biotechnol Bioeng. 2015 Jun;112(6):1102-10. doi: 10.1002/bit.25537. Epub 2015 Apr 17.

15.

Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication.

Lee JS, Lee YN, Lee YT, Hwang HS, Kim KH, Ko EJ, Kim MC, Kang SM.

Nutrients. 2015 Feb 4;7(2):1021-36. doi: 10.3390/nu7021021.

16.

Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.

Lee JS, Kwon YM, Hwang HS, Lee YN, Ko EJ, Yoo SE, Kim MC, Kim KH, Cho MK, Lee YT, Lee YR, Quan FS, Kang SM.

Vaccine. 2014 Oct 7;32(44):5866-74. doi: 10.1016/j.vaccine.2014.08.045. Epub 2014 Aug 27.

17.

Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity.

Kim MC, Lee YN, Hwang HS, Lee YT, Ko EJ, Jung YJ, Cho MK, Kim YJ, Lee JS, Ha SH, Kang SM.

Vaccine. 2014 Oct 7;32(44):5824-31. doi: 10.1016/j.vaccine.2014.08.030. Epub 2014 Aug 27.

18.

Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.

Hwang HS, Kwon YM, Lee JS, Yoo SE, Lee YN, Ko EJ, Kim MC, Cho MK, Lee YT, Jung YJ, Lee JY, Li JD, Kang SM.

Antiviral Res. 2014 Oct;110:115-23. doi: 10.1016/j.antiviral.2014.07.016. Epub 2014 Aug 7.

19.

Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.

Ko EJ, Kwon YM, Lee JS, Hwang HS, Yoo SE, Lee YN, Lee YT, Kim MC, Cho MK, Lee YR, Quan FS, Song JM, Lee S, Moore ML, Kang SM.

Nanomedicine. 2015 Jan;11(1):99-108. doi: 10.1016/j.nano.2014.07.013. Epub 2014 Aug 8.

20.

Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses.

Lee JS, Cho MK, Hwang HS, Ko EJ, Lee YN, Kwon YM, Kim MC, Kim KH, Lee YT, Jung YJ, Kang SM.

J Interferon Cytokine Res. 2014 Nov;34(11):902-14. doi: 10.1089/jir.2013.0093. Epub 2014 Jul 22.

Supplemental Content

Support Center